Alan Edmund Walts - Oct 16, 2024 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
Director
Signature
/s/ Sumit Aggarwal, Attorney-in-Fact for Alan Edmund Walts
Stock symbol
ELOX
Transactions as of
Oct 16, 2024
Transactions value $
$0
Form type
4
Date filed
10/17/2024, 04:02 PM
Previous filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELOX Common Stock Award $0 +12K +1273.89% $0.00 12.9K Oct 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Remarks:

On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share counts herein reflect the reverse stock split.